These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 25569348)
21. [Triplet repeat disease, with particular emphasis of spinal and bulbar muscular atrophy (SBMA)]. Sobue G Rinsho Shinkeigaku; 2000 Dec; 40(12):1193-5. PubMed ID: 11464455 [TBL] [Abstract][Full Text] [Related]
22. Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes. Milioto C; Malena A; Maino E; Polanco MJ; Marchioretti C; Borgia D; Pereira MG; Blaauw B; Lieberman AP; Venturini R; Plebani M; Sambataro F; Vergani L; Pegoraro E; Sorarù G; Pennuto M Sci Rep; 2017 Jan; 7():41046. PubMed ID: 28117338 [TBL] [Abstract][Full Text] [Related]
23. Progress in Spinobulbar muscular atrophy research: insights into neuronal dysfunction caused by the polyglutamine-expanded androgen receptor. Beitel LK; Scanlon T; Gottlieb B; Trifiro MA Neurotox Res; 2005; 7(3):219-30. PubMed ID: 15897156 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Palazzolo I; Stack C; Kong L; Musaro A; Adachi H; Katsuno M; Sobue G; Taylor JP; Sumner CJ; Fischbeck KH; Pennuto M Neuron; 2009 Aug; 63(3):316-28. PubMed ID: 19679072 [TBL] [Abstract][Full Text] [Related]
25. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330 [TBL] [Abstract][Full Text] [Related]
26. Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy. Todd TW; Kokubu H; Miranda HC; Cortes CJ; La Spada AR; Lim J Elife; 2015 Aug; 4():e08493. PubMed ID: 26308581 [TBL] [Abstract][Full Text] [Related]
27. Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity. Suzuki E; Zhao Y; Ito S; Sawatsubashi S; Murata T; Furutani T; Shirode Y; Yamagata K; Tanabe M; Kimura S; Ueda T; Fujiyama S; Lim J; Matsukawa H; Kouzmenko AP; Aigaki T; Tabata T; Takeyama K; Kato S Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3818-22. PubMed ID: 19237573 [TBL] [Abstract][Full Text] [Related]
28. Blocking the dimerization of polyglutamine-expanded androgen receptor protects cells from DHT-induced toxicity by increasing AR turnover. Lisberg A; Liu Y; Merry DE J Biol Chem; 2024 May; 300(5):107246. PubMed ID: 38556081 [TBL] [Abstract][Full Text] [Related]
29. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Abel A; Walcott J; Woods J; Duda J; Merry DE Hum Mol Genet; 2001 Jan; 10(2):107-16. PubMed ID: 11152658 [TBL] [Abstract][Full Text] [Related]
30. Human adipose-derived mesenchymal stem cells as a new model of spinal and bulbar muscular atrophy. Dossena M; Bedini G; Rusmini P; Giorgetti E; Canazza A; Tosetti V; Salsano E; Sagnelli A; Mariotti C; Gellera C; Navone SE; Marfia G; Alessandri G; Corsi F; Parati EA; Pareyson D; Poletti A PLoS One; 2014; 9(11):e112746. PubMed ID: 25392924 [TBL] [Abstract][Full Text] [Related]